(2R)-3-[[(3S,6R,9R,10S,13S,16S)-13-(2-amino-2-oxoethyl)-6-(3-amino-3-oxopropyl)-10-methyl-2,5,8,12,15-pentaoxo-3-propan-2-yl-11-oxa-1,4,7,14-tetrazabicyclo[14.3.0]nonadecan-9-yl]amino]-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-[[2-[[(2S)-1-[3-(4-bromophenyl)-2-[[(2S)-2-formamidopropanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3,3-dimethylbutanoyl]amino]-3,3-dimethylpentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-oxopropane-1-sulfonic acid
| Internal ID | cabc21dc-b498-4c8e-bc2e-cd0e4457a2b0 |
| Taxonomy | Organic acids and derivatives > Peptidomimetics > Depsipeptides > Cyclic depsipeptides |
| IUPAC Name | (2R)-3-[[(3S,6R,9R,10S,13S,16S)-13-(2-amino-2-oxoethyl)-6-(3-amino-3-oxopropyl)-10-methyl-2,5,8,12,15-pentaoxo-3-propan-2-yl-11-oxa-1,4,7,14-tetrazabicyclo[14.3.0]nonadecan-9-yl]amino]-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-[[2-[[(2S)-1-[3-(4-bromophenyl)-2-[[(2S)-2-formamidopropanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-3,3-dimethylbutanoyl]amino]-3,3-dimethylpentanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-oxopropane-1-sulfonic acid |
| SMILES (Canonical) | CCC(C)(C)C(C(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CCCN=C(N)N)C(=O)NC(CS(=O)(=O)O)C(=O)NC3C(OC(=O)C(NC(=O)C4CCCN4C(=O)C(NC(=O)C(NC3=O)CCC(=O)N)C(C)C)CC(=O)N)C)NC(=O)C(C(C)(C)C)NC(=O)C5CCCN5C(=O)C(CC6=CC=C(C=C6)Br)NC(=O)C(C)NC=O |
| SMILES (Isomeric) | CCC(C)(C)[C@H](C(=O)N[C@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@H](CCCN=C(N)N)C(=O)N[C@@H](CS(=O)(=O)O)C(=O)N[C@@H]3[C@@H](OC(=O)[C@@H](NC(=O)[C@@H]4CCCN4C(=O)[C@@H](NC(=O)[C@H](NC3=O)CCC(=O)N)C(C)C)CC(=O)N)C)NC(=O)C(C(C)(C)C)NC(=O)[C@@H]5CCCN5C(=O)C(CC6=CC=C(C=C6)Br)NC(=O)[C@H](C)NC=O |
| InChI | InChI=1S/C74H108BrN19O20S/c1-11-74(9,10)58(92-67(106)57(73(6,7)8)91-65(104)52-21-15-29-93(52)69(108)48(86-59(98)38(4)82-36-95)31-40-22-24-42(75)25-23-40)68(107)85-47(32-41-34-81-44-18-13-12-17-43(41)44)62(101)83-45(19-14-28-80-72(78)79)60(99)88-50(35-115(111,112)113)63(102)90-56-39(5)114-71(110)49(33-54(77)97)87-64(103)51-20-16-30-94(51)70(109)55(37(2)3)89-61(100)46(84-66(56)105)26-27-53(76)96/h12-13,17-18,22-25,34,36-39,45-52,55-58,81H,11,14-16,19-21,26-33,35H2,1-10H3,(H2,76,96)(H2,77,97)(H,82,95)(H,83,101)(H,84,105)(H,85,107)(H,86,98)(H,87,103)(H,88,99)(H,89,100)(H,90,102)(H,91,104)(H,92,106)(H4,78,79,80)(H,111,112,113)/t38-,39-,45+,46+,47+,48?,49-,50-,51-,52-,55-,56+,57?,58-/m0/s1 |
| InChI Key | KDPZREDHSDXDIZ-JSBRDQSLSA-N |
| Popularity | 1 reference in papers |
| Molecular Formula | C74H108BrN19O20S |
| Molecular Weight | 1695.70 g/mol |
| Exact Mass | 1693.69221 g/mol |
| Topological Polar Surface Area (TPSA) | 616.00 Ų |
| XlogP | 0.00 |
| Atomic LogP (AlogP) | -3.15 |
| H-Bond Acceptor | 20 |
| H-Bond Donor | 17 |
| Rotatable Bonds | 35 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.8304 | 83.04% |
| Caco-2 | - | 0.8629 | 86.29% |
| Blood Brain Barrier | - | 0.8000 | 80.00% |
| Human oral bioavailability | - | 0.6857 | 68.57% |
| Subcellular localzation | Lysosomes | 0.4954 | 49.54% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8038 | 80.38% |
| OATP1B3 inhibitior | + | 0.9301 | 93.01% |
| MATE1 inhibitior | - | 0.7209 | 72.09% |
| OCT2 inhibitior | - | 0.6500 | 65.00% |
| BSEP inhibitior | + | 0.9703 | 97.03% |
| P-glycoprotein inhibitior | + | 0.7419 | 74.19% |
| P-glycoprotein substrate | + | 0.8743 | 87.43% |
| CYP3A4 substrate | + | 0.7648 | 76.48% |
| CYP2C9 substrate | - | 0.5986 | 59.86% |
| CYP2D6 substrate | - | 0.8413 | 84.13% |
| CYP3A4 inhibition | - | 0.6798 | 67.98% |
| CYP2C9 inhibition | - | 0.6980 | 69.80% |
| CYP2C19 inhibition | - | 0.6523 | 65.23% |
| CYP2D6 inhibition | - | 0.8484 | 84.84% |
| CYP1A2 inhibition | - | 0.7122 | 71.22% |
| CYP2C8 inhibition | + | 0.8511 | 85.11% |
| CYP inhibitory promiscuity | - | 0.7633 | 76.33% |
| UGT catelyzed | - | 0.0000 | 0.00% |
| Carcinogenicity (binary) | + | 0.5200 | 52.00% |
| Carcinogenicity (trinary) | Non-required | 0.5524 | 55.24% |
| Eye corrosion | - | 0.9758 | 97.58% |
| Eye irritation | - | 0.8954 | 89.54% |
| Skin irritation | - | 0.7565 | 75.65% |
| Skin corrosion | - | 0.9091 | 90.91% |
| Ames mutagenesis | - | 0.6500 | 65.00% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.7057 | 70.57% |
| Micronuclear | + | 0.9300 | 93.00% |
| Hepatotoxicity | - | 0.5277 | 52.77% |
| skin sensitisation | - | 0.8260 | 82.60% |
| Respiratory toxicity | + | 0.7778 | 77.78% |
| Reproductive toxicity | + | 0.8667 | 86.67% |
| Mitochondrial toxicity | + | 0.5375 | 53.75% |
| Nephrotoxicity | - | 0.6841 | 68.41% |
| Acute Oral Toxicity (c) | III | 0.5690 | 56.90% |
| Estrogen receptor binding | - | 0.5598 | 55.98% |
| Androgen receptor binding | + | 0.7322 | 73.22% |
| Thyroid receptor binding | + | 0.8103 | 81.03% |
| Glucocorticoid receptor binding | + | 0.8437 | 84.37% |
| Aromatase binding | + | 0.8229 | 82.29% |
| PPAR gamma | + | 0.7794 | 77.94% |
| Honey bee toxicity | - | 0.6070 | 60.70% |
| Biodegradation | - | 0.8750 | 87.50% |
| Crustacea aquatic toxicity | - | 0.5200 | 52.00% |
| Fish aquatic toxicity | + | 0.9894 | 98.94% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL333 | P08253 | Matrix metalloproteinase-2 | 99.99% | 96.31% |
| CHEMBL3837 | P07711 | Cathepsin L | 99.90% | 96.61% |
| CHEMBL2581 | P07339 | Cathepsin D | 99.86% | 98.95% |
| CHEMBL321 | P14780 | Matrix metalloproteinase 9 | 99.75% | 92.12% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 99.53% | 97.64% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 99.52% | 94.66% |
| CHEMBL230 | P35354 | Cyclooxygenase-2 | 99.42% | 89.63% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 99.09% | 91.11% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 99.08% | 98.33% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 98.92% | 96.09% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 98.91% | 95.38% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 98.89% | 90.08% |
| CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 98.74% | 95.56% |
| CHEMBL4644 | P41968 | Melanocortin receptor 3 | 98.16% | 99.52% |
| CHEMBL5043 | Q6P179 | Endoplasmic reticulum aminopeptidase 2 | 97.88% | 91.81% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 97.54% | 95.89% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 97.26% | 97.09% |
| CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 97.07% | 82.69% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 95.20% | 97.14% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 95.16% | 82.38% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 94.92% | 98.24% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 94.48% | 97.23% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 94.47% | 98.05% |
| CHEMBL3310 | Q96DB2 | Histone deacetylase 11 | 94.38% | 88.56% |
| CHEMBL261 | P00915 | Carbonic anhydrase I | 94.35% | 96.76% |
| CHEMBL325 | Q13547 | Histone deacetylase 1 | 94.32% | 95.92% |
| CHEMBL4073 | P09237 | Matrix metalloproteinase 7 | 94.29% | 97.56% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 93.89% | 89.00% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 93.76% | 97.25% |
| CHEMBL4296 | Q15858 | Sodium channel protein type IX alpha subunit | 93.55% | 96.11% |
| CHEMBL3729 | P22748 | Carbonic anhydrase IV | 93.43% | 99.23% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 92.41% | 100.00% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 92.31% | 96.47% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 92.07% | 99.17% |
| CHEMBL1907605 | P24864 | Cyclin-dependent kinase 2/cyclin E1 | 92.00% | 92.88% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 91.89% | 100.00% |
| CHEMBL4051 | P13569 | Cystic fibrosis transmembrane conductance regulator | 91.80% | 95.71% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 91.78% | 100.00% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 91.60% | 94.45% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 91.51% | 96.90% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 91.00% | 88.42% |
| CHEMBL3476 | O15111 | Inhibitor of nuclear factor kappa B kinase alpha subunit | 90.38% | 95.83% |
| CHEMBL4801 | P29466 | Caspase-1 | 89.77% | 96.85% |
| CHEMBL4123 | P30989 | Neurotensin receptor 1 | 89.56% | 96.67% |
| CHEMBL5203 | P33316 | dUTP pyrophosphatase | 89.36% | 99.18% |
| CHEMBL2535 | P11166 | Glucose transporter | 89.19% | 98.75% |
| CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 88.03% | 99.23% |
| CHEMBL1907600 | Q00535 | Cyclin-dependent kinase 5/CDK5 activator 1 | 87.86% | 93.03% |
| CHEMBL5939 | Q9NZ08 | Endoplasmic reticulum aminopeptidase 1 | 87.85% | 100.00% |
| CHEMBL3524 | P56524 | Histone deacetylase 4 | 87.50% | 92.97% |
| CHEMBL5966 | P55899 | IgG receptor FcRn large subunit p51 | 87.40% | 90.93% |
| CHEMBL1744525 | P43490 | Nicotinamide phosphoribosyltransferase | 87.26% | 96.25% |
| CHEMBL4685 | P14902 | Indoleamine 2,3-dioxygenase | 87.10% | 96.38% |
| CHEMBL4393 | P39900 | Matrix metalloproteinase 12 | 86.97% | 92.22% |
| CHEMBL1937 | Q92769 | Histone deacetylase 2 | 86.76% | 94.75% |
| CHEMBL1801 | P00747 | Plasminogen | 86.38% | 92.44% |
| CHEMBL5028 | O14672 | ADAM10 | 86.28% | 97.50% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 85.86% | 93.56% |
| CHEMBL1163125 | O60885 | Bromodomain-containing protein 4 | 85.81% | 97.31% |
| CHEMBL1907599 | P05556 | Integrin alpha-4/beta-1 | 85.13% | 92.86% |
| CHEMBL4895 | P30530 | Tyrosine-protein kinase receptor UFO | 84.35% | 90.95% |
| CHEMBL1902 | P62942 | FK506-binding protein 1A | 83.74% | 97.05% |
| CHEMBL4608 | P33032 | Melanocortin receptor 5 | 83.58% | 97.00% |
| CHEMBL1293287 | P14735 | Insulin-degrading enzyme | 82.51% | 88.10% |
| CHEMBL283 | P08254 | Matrix metalloproteinase 3 | 82.45% | 97.29% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 82.26% | 93.00% |
| CHEMBL2635 | P51452 | Dual specificity protein phosphatase 3 | 82.25% | 94.00% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 82.18% | 95.00% |
| CHEMBL2803 | P43403 | Tyrosine-protein kinase ZAP-70 | 81.90% | 82.50% |
| CHEMBL3430907 | Q96GD4 | Aurora kinase B/Inner centromere protein | 81.54% | 97.50% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 101622255 |
| LOTUS | LTS0180839 |
| wikiData | Q105139319 |